Febuxostat Tablets Market

The main component of non-bubuxostat is non-bubuxostat, and its chemical name is 2-[(3-cyanogroup - 4-isobutyl oxygen group) phenyl] -4-methyl-5-thiazole carboxylic acid.Xanthine oxidase (XO) inhibitor for the long-term treatment of hyperuricemia with gout symptoms.
Febuxostat Tablets Market contains market size and forecasts of Febuxostat Tablets in global, including the following market information:
Global Febuxostat Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Febuxostat Tablets Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Febuxostat Tablets companies in 2021 (%)
The global Febuxostat Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
40 Mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Febuxostat Tablets include Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan and Teijin Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Febuxostat Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Febuxostat Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Febuxostat Tablets Market Segment Percentages, by Type, 2021 (%)
40 Mg Tablet
80 Mg Tablet
120 Mg Tablet
20 Mg Tablet
Global Febuxostat Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Febuxostat Tablets Market Segment Percentages, by Application, 2021 (%)
Hyperuricemia
Tumor Lysis Syndrome
Angina Pectoris
Other
Global Febuxostat Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Febuxostat Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Febuxostat Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Febuxostat Tablets revenues share in global market, 2021 (%)
Key companies Febuxostat Tablets sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Febuxostat Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Menarini Group
Takeda Pharmaceuticals
MACLEODS
Prinston Pharmaceutical
Alembic Pharmaceuticals
Hikma Pharmaceuticals
Lupin Limited
Mylan
Teijin Pharma
Hengrui Pharma
Sun Pharma
Msn Laboratories
Golden State Medical
Novadoz Pharmaceuticals
Astellas Pharma
SK Holdings
Ipsen
Hangzhou Zhuyangxin Pharmaceutical
Jiangsu Wanbang Biochemical Pharmaceutical Group
Tianjin Pacific Pharmaceutical